Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 260,354 shares of VCEL, which is worth approximately $10.2 Million. The most recent transaction as insider was on Sep 11, 2024, when has been sold 17,500 shares (Common Stock) at a price of $3.02 per share, resulting in proceeds of $52,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

17.84% 3M change

17.94% 12M change

Total Value Held $10.2 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 15 2024	SELL Open market or private sale	$809,200 $46.24 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 14 2024	SELL Open market or private sale	$790,475 $45.17 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 18 2024	SELL Open market or private sale	$899,500 $51.4 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 17 2024	SELL Open market or private sale	$902,125 $51.55 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Jul 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jun 13 2024	SELL Open market or private sale	$754,250 $43.1 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
Jun 12 2024	SELL Open market or private sale	$772,100 $44.12 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
May 16 2024	SELL Open market or private sale	$837,375 $47.85 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
May 15 2024	SELL Open market or private sale	$869,225 $49.67 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
Apr 30 2024	BUY Exercise of conversion of derivative security	$354,957 $13.95 p/Share	25,445 Added 10.34%	220,752 Common Stock
Apr 18 2024	SELL Open market or private sale	$780,325 $44.59 p/Share	17,500 Reduced 8.22%	195,307 Common Stock
Apr 18 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 7.6%	212,807 Common Stock
Apr 17 2024	SELL Open market or private sale	$813,225 $46.47 p/Share	17,500 Reduced 8.22%	195,307 Common Stock
Apr 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 7.6%	212,807 Common Stock
Mar 14 2024	SELL Open market or private sale	$770,350 $44.02 p/Share	17,500 Reduced 8.24%	194,870 Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 7.61%	212,370 Common Stock
Mar 13 2024	SELL Open market or private sale	$781,725 $44.67 p/Share	17,500 Reduced 8.24%	194,870 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare